The National Pharmaceutical Pricing Authority (NPPA), exercising powers under paragraphs 5, 11, and 15 of the Drugs (Prices Control) Order, 2013, has notified the fixation of retail prices for specified new drug formulations. The prices, exclusive of Goods and Services Tax, apply to the formulations listed with defined strength, unit, manufacturer, and marketing company. Manufacturers of drugs classified as “new drugs” under DPCO 2013 must strictly adhere to the notified retail price. GST may be added only if it is actually paid or payable to the government.
Retail prices for individual packs must be calculated as per paragraph 11 of DPCO 2013. Manufacturers are required to issue and submit price lists in Form V through the Integrated Pharmaceutical Database Management System and share copies with State Drug Controllers and dealers. Retailers and dealers must prominently display these price lists at their business premises.
The applicability of the notified price is limited to manufacturers or marketers who have applied for price fixation or revision and fulfilled all statutory requirements, including valid licensing approvals. Non-compliance will attract recovery of overcharged amounts with interest under DPCO 2013 and the Essential Commodities Act, 1955. Prior price orders for the same formulations stand superseded.